Xeris Biopharma Holdings, Inc.
US ˙ NasdaqGS ˙ US98422E1038

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey W Sherman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey W Sherman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:XERS / Xeris Biopharma Holdings, Inc. Director 219.188
US:HZNP / Horizon Therapeutics Plc EVP and Chief Medical Officer 0
US:SBBP / Strongbridge Biopharma plc Director 0
Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey W Sherman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb XERS / Xeris Biopharma Holdings, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i XERS / Xeris Biopharma Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-11-27 XERS SHERMAN JEFFREY W 5.400 1,8700 5.400 1,8700 10.098 347 3.4700 8.640 85,56

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XERS / Xeris Biopharma Holdings, Inc. Insider Trades
Insidersalg XERS / Xeris Biopharma Holdings, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i XERS / Xeris Biopharma Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-08-28 XERS SHERMAN JEFFREY W 42.232 7,9209 42.232 7,9209 334.515 18 7.3600 -23.687 -7,08

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XERS / Xeris Biopharma Holdings, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey W Sherman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-29 2025-08-28 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
S - Sale -42.232 219.188 -16,15 7,92 -334.515 1.736.166
2025-08-29 2025-08-28 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
M - Exercise 47.040 261.420 21,94 6,66 313.286 1.741.057
2025-06-04 2025-06-04 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
A - Award 50.000 214.380 30,42
2024-06-05 2024-06-05 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
A - Award 50.000 164.380 43,71
2024-04-11 2024-03-15 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
J - Other 6.502 114.380 6,03
2023-11-29 2023-11-27 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
P - Purchase 5.400 5.400 1,87 10.098 10.098
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -45.352 0 -100,00 116,50 -5.283.508
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -80.944 0 -100,00 116,50 -9.429.976
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -105.808 0 -100,00 116,50 -12.326.632
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -2.655 0 -100,00 116,50 -309.308
2023-09-07 2023-09-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -2.165 80.944 -2,61
2023-06-07 2023-06-07 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
A - Award 42.500 107.878 65,01
2023-01-18 2023-01-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 33.795 83.109 68,53
2023-01-18 2023-01-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -33.795 2.376 -93,43
2023-01-12 2023-01-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3.368 36.171 -8,52 113,10 -380.921 4.090.940
2023-01-12 2023-01-10 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3.368 39.539 -7,85 113,05 -380.752 4.469.884
2023-01-06 2023-01-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.187 49.314 -9,52 113,29 -587.635 5.586.783
2023-01-06 2023-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -22.655 42.907 -34,56 113,24 -2.565.452 4.858.789
2023-01-06 2023-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 51.132 65.562 354,35
2023-01-04 2023-01-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -9.717 14.430 -40,24 113,80 -1.105.795 1.642.134
2023-01-04 2023-01-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 21.772 24.147 916,72
2022-12-13 2022-12-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -21.378 84.430 -20,20 111,45 -2.382.484 9.409.352
2022-12-13 2022-12-12 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.974 54.501 -11,34 111,44 -777.208 6.073.788
2022-12-13 2022-05-27 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 8.531 61.475 16,11
2022-12-13 2022-05-27 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -8.531 2.375 -78,22
2022-06-09 2022-06-08 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
A - Award 15.000 65.378 29,77
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -42.009 10.629 -79,81 110,02 -4.621.872 1.169.413
2022-03-21 2022-03-18 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -8.531 164.469 -4,93
2022-03-21 2022-03-18 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 8.531 52.638 19,34 22,14 188.876 1.165.405
2022-03-21 2022-03-10 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 8.169 52.944 18,24
2022-03-21 2022-03-10 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -8.169 44.107 -15,63
2022-03-21 2021-06-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 5.287 52.276 11,25
2022-03-21 2021-06-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -5.287 44.775 -10,56
2022-03-21 2021-05-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 12.304 50.062 32,59
2022-03-21 2021-05-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -12.304 46.989 -20,75
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -5.354 0 -100,00
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.372 59.293 -3,85 86,42 -204.988 5.124.101
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.354 61.665 9,51
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.314 18.628 -33,33
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.678 4.834 -66,69
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9.222 9.223 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.095 12.095 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.261 0 -100,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -37.675 56.311 -40,09
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 32.301 93.986 52,36
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 52.570 61.685 576,74
2022-01-06 2022-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 19.044 19.044
2022-01-06 2021-12-13 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -50 37.758 -0,13
2022-01-06 2021-11-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 10.729 37.808 39,62
2022-01-06 2021-11-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -10.729 9.115 -54,07
2021-10-29 2021-10-27 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -10.729 0 -100,00
2021-10-29 2021-10-27 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 10.729 19.844 117,71 7,61 81.648 151.013
2021-10-06 2021-10-05 4 SBBP Strongbridge Biopharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -140.000 0 -100,00
2021-10-06 2021-10-05 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
D - Sale to Issuer -64.258 0 -100,00
2021-10-05 2021-10-05 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -11.228 0 -100,00
2021-10-05 2021-10-05 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -11.228 0 -100,00
2021-10-05 2021-10-05 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2021-10-05 2021-10-05 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -19.650 0 -100,00
2021-10-05 2021-10-01 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
F - Taxes -17.763 64.258 -21,66 2,06 -36.592 132.371
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 11.228 11.228
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 11.228 11.228
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 19.650 19.650
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 31.360 31.360
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 31.360 31.360
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Stock Option (Right to Buy)
A - Award 47.040 47.040
2021-10-05 2021-10-05 4 XERS Xeris Biopharma Holdings, Inc.
Common Stock
A - Award 50.378 50.378
2021-09-23 2021-09-21 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -46.271 10.729 -81,18
2021-09-23 2021-09-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -46.271 9.115 -83,54 110,00 -5.089.810 1.002.650
2021-09-23 2021-09-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 46.271 55.386 507,64 7,61 352.122 421.487
2021-09-23 2021-09-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 4.042 27.079 17,55
2021-09-23 2021-09-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -4.042 9.115 -30,72
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 14.514 14.514
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3.215 13.157 -19,64 102,50 -329.538 1.348.592
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 7.257 16.372 79,62
2021-07-02 2021-07-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -54.789 128.845 -29,84 95,00 -5.205.097 12.240.610
2021-07-02 2021-07-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.287 9.115 -36,71 95,00 -502.265 865.925
2021-07-02 2021-03-10 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 66.730 66.730
2021-07-02 2021-03-10 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -66.730 14.402 -82,25
2021-06-08 2021-06-08 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 11.228 11.228
2021-05-18 2021-05-18 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
A - Award 40.000 82.021 95,19
2021-05-17 2021-05-14 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
F - Taxes -18.944 42.021 -31,07 2,35 -44.518 98.749
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 14.512 14.512
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 3.931 3.931
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -871 80.083 -1,08 87,17 -75.925 6.980.835
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 1.965 80.954 2,49
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -5.353 5.354 -50,00
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.372 78.989 -2,92 77,43 -183.664 6.116.118
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.353 81.361 7,04
2021-01-22 2020-12-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 8.679 183.634 4,96
2021-01-22 2020-12-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -8.679 76.008 -10,25
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.094 24.190 -33,33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.260 0 -100,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12.261 12.261 -50,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -45.256 84.687 -34,83 73,28 -3.316.360 6.205.863
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 60.313 129.943 86,62
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 41.615 69.630 148,55
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 27.942 27.942
2020-12-09 2020-12-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -31.133 174.955 -15,11 71,32 -2.220.406 12.477.791
2020-12-09 2020-12-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -9.631 206.088 -4,46 70,60 -679.949 14.549.813
2020-12-09 2020-12-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -10.489 215.719 -4,64 72,24 -757.725 15.583.541
2020-12-09 2020-12-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -16.200 226.208 -6,68 71,52 -1.158.624 16.178.396
2020-12-09 2020-12-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -36.389 242.408 -13,05 70,31 -2.558.511 17.043.706
2020-10-22 2020-10-21 4/A HZNP Horizon Therapeutics Public Ltd Co
Stock option (right to buy)
M - Exercise -13.000 57.000 -18,57
2020-10-22 2020-10-21 4/A HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 13.000 28.015 86,58 7,61 98.930 213.194
2020-10-21 2020-10-21 4 HZNP Horizon Therapeutics Public Ltd Co
Stock option (right to buy)
M - Exercise -13.000 57.000 -18,57
2020-10-21 2020-10-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 13.000 28.015 86,58 7,61 98.930 213.194
2020-07-07 2020-07-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -9.100 278.797 -3,16 57,50 -523.250 16.030.828
2020-06-04 2020-06-04 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 11.228 11.228
2020-05-18 2020-05-15 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
F - Taxes -19.035 60.965 -23,79 2,86 -54.440 174.360
2020-05-15 2020-05-14 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
A - Award 40.000 80.000 100,00
2020-05-12 2020-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Stock option (right to buy)
M - Exercise -33.479 0 -100,00
2020-05-12 2020-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -33.479 13.966 -70,56 45,00 -1.506.555 628.470
2020-05-12 2020-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 33.479 47.445 239,72 4,96 166.056 235.327
2020-03-13 2020-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Stock option (right to buy)
M - Exercise -5.287 0 -100,00
2020-03-13 2020-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.287 13.966 60,92 12,94 68.414 180.720
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
305.255
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
584.473
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
305.255
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
584.473
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
305.255
2020-02-28 3 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
584.473
2019-05-16 2019-05-15 4 SBBP Strongbridge Biopharma plc
Ordinary Shares
A - Award 40.000 40.000
2019-03-01 2019-02-27 4 XERS XERIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2018-05-17 2018-05-15 4 SBBP Strongbridge Biopharma plc
Stock Options (Right to Buy)
A - Award 40.000 40.000
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 19.250 -50,00
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.528 212.341 -3,86 13,86 -118.198 2.943.046
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 220.869 9,55
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -15.500 0 -100,00
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7.680 201.619 -3,67 15,02 -115.354 3.028.317
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 15.500 209.299 8,00
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 38.500 -33,33
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.798 192.350 -4,37 14,56 -128.099 2.800.616
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 201.148 10,58
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -15.500 15.500 -50,00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -11.250 0 -100,00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -12.602 181.898 -6,48 16,18 -203.900 2.943.110
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 26.750 194.500 15,95
2016-12-19 2016-12-16 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -8.500 5.313 -61,54
2016-12-19 2016-12-16 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8.500 167.750 5,34 2,40 20.400 402.600
2016-08-02 2016-08-02 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -2.900 159.250 -1,79 20,00 -58.000 3.185.000
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -19.250 57.750 -25,00
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.798 160.100 -5,21 16,32 -143.583 2.612.832
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 19.250 168.898 12,86
2016-02-29 2016-02-26 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -4.100 149.648 -2,67 20,00 -82.000 2.992.960
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -15.500 31.000 -33,33
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -11.250 11.250 -50,00
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.576 153.748 -5,28 21,67 -185.842 3.331.719
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 26.750 162.324 19,73
2015-12-16 2015-12-15 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -17.692 33.479 -34,57
2015-12-16 2015-12-15 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -12.750 13.813 -48,00
2015-12-16 2015-12-15 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 17.692 135.574 15,01 4,96 87.752 672.447
2015-12-16 2015-12-15 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 12.750 117.882 12,13 2,40 30.600 282.917
2015-12-10 2015-12-10 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X 4.456 105.132 4,43 20,00 89.120 2.102.640
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8.208 0 -100,00
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3.752 109.588 -3,31 20,40 -76.541 2.235.595
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8.208 113.340 7,81
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8.208 0 -100,00
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3.752 109.588 -3,31 21,40 -80.293 2.345.183
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8.208 113.340 7,81
2015-09-21 2015-09-21 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -7.750 105.132 -6,87 31,78 -246.295 3.341.095
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -2.450 51.171 -4,57
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -24.437 26.563 -47,92
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -2.450 112.882 -2,12 35,55 -87.098 4.012.955
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 2.450 115.332 2,17 4,96 12.152 572.047
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -24.437 112.882 -17,80 35,55 -868.735 4.012.955
2015-07-17 2015-07-15 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 24.437 137.319 21,65 2,40 58.649 329.566
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 558.000 558.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 186.000 186.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 77.000 77.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 173.000 173.000
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8.208 8.208 -50,00
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -2.656 84.336 -3,05 12,99 -34.501 1.095.525
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8.208 86.992 10,42
2015-01-26 2014-01-02 4/A HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -11.250 33.750 -25,00
2015-01-26 2014-01-02 4/A HZNP Horizon Pharma plc
Common Stock
M - Exercise 11.250 102.596 12,32
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Restricted stock units
M - Exercise -15.500 46.500 -25,00
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Restricted stock units
M - Exercise -11.250 22.500 -33,33
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Ordinary shares
F - Taxes -8.753 102.333 -7,88 12,80 -112.038 1.309.862
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Ordinary shares
M - Exercise 26.750 111.086 31,72
2014-11-20 2014-11-19 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale -24.999 74.299 -25,18 12,05 -301.238 895.303
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -62.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -70.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -33.750 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -51.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -16.416 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -53.621 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -42.295 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -47.654 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -46.335 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Common Stock
D - Sale to Issuer -99.298 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 62.000 62.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 70.000 70.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 33.750 33.750
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 51.000 51.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 16.416 16.416
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 53.621 53.621
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 42.295 42.295
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 47.654 47.654
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 46.335 46.335
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 99.298 99.298
2014-05-21 2014-05-19 4 HZNP HORIZON PHARMA, INC.
Common stock
S - Sale X -9.361 93.235 -9,12 12,94 -121.131 1.206.461
2014-01-10 2014-01-02 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
A - Award 62.000 62.000
2014-01-10 2014-01-02 4 HZNP HORIZON PHARMA, INC.
Employee stock options (right to buy)
A - Award 70.000 70.000
2013-12-09 2013-12-09 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
M - Exercise -8.208 16.416 -33,33
2013-12-09 2013-12-09 4 HZNP HORIZON PHARMA, INC.
Common Stock
M - Exercise 8.208 91.346 9,87
2013-12-09 2013-12-05 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 18.037 83.138 27,71
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
A - Award 45.000 45.000
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Employee stock options (right to buy)
A - Award 51.000 51.000
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Common Stock
S - Sale X 16.304 55.099 42,03 2,36 38.477 130.034
2012-12-12 2012-12-10 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
M - Exercise -8.208 24.624 -25,00
2012-12-12 2012-12-10 4 HZNP HORIZON PHARMA, INC.
Common Stock
M - Exercise 8.208 71.403 12,99
2012-07-27 2012-07-26 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 33.000 61.105 117,42
2012-03-07 2012-03-02 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 22.000 22.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)